[1] WINIFRED NOMPUMELELO SIMELANE N, ABRAHAMSE H. Nanoparticle-mediated delivery systems in photodynamic therapy of colorectal cancer [J]. Int J Mol Sci, 2021, 22(22): 12405. DOI: 10.3390/ijms222212405.
[2] MONTASERI H, KRUGER C A, ABRAHAMSE H. Review: organic nanoparticle based active targeting for photodynamic therapy treatment of breast cancer cells [J]. Oncotarget, 2020, 11(22): 2120-2136.
[3] JI B, WEI M, YANG B. Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy [J]. Theranostics, 2022, 12(1): 434-458.
[4] KEENE J P, KESSEL D, LAND E J, et al. Direct detection of singlet oxygen sensitized by haematoporphyrin and related compounds [J]. Photochem Photobiol, 1986, 43(2): 117-120.
[5] HU T, WANG Z, SHEN W, et al. Recent advances in innovative strategies for enhanced cancer photodynamic therapy [J]. Theranostics, 2021, 11(7): 3278-3300.
[6] CASTER J M, CALLAGHAN C, SEYEDIN S N, et al. Optimizing advances in nanoparticle delivery for cancer immunotherapy [J]. Adv Drug Deliv Rev, 2019, 144: 3-15.
[7] PHAM T C, NGUYEN V N, CHOI Y, et al. Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy[J]. Chem Rev, 2021,121(21):13454-13619.
[8] COLOMBEAU L, ACHERAR S, BAROS F, et al. Inorganic nanoparticles for photodynamic therapy [J]. Top Curr Chem, 2016, 370(4): 113-134.
[9] MONTASERI H, KRUGER C A, ABRAHAMSE H. Inorganic nanoparticles applied for active targeted photodynamic therapy of breast cancer [J]. Pharmaceutics, 2021, 13(3): 296. DOI: 10.3390/pharmaceutics13030296.
[10] HOU Y J, YANG X X, LIU R Q, et al. Pathological mechanism of photodynamic therapy and photothermal therapy based on nanoparticles [J]. Int J Nanomed, 2020, 15: 6827-6838.
[11] JIN F, WANG H, LI Q, et al. Clinical application of photodynamic therapy for malignant airway tumors in China [J]. Thorac Cancer, 2020, 11(1): 181-190.
[12] YOUNIS M R, HE G, QU J, et al. Inorganic nanomaterials with intrinsic singlet oxygen generation for photodynamic therapy [J]. Adv Sci (Weinh), 2021, 8(21): e2102587. DOI: 10.1002/advs.202102587.
[13] KWIATKOWSKI S, KNAP B, PRZYSTUPSKI D, et al. Photodynamic therapy-mechanisms, photosensitizers and combinations [J]. Biomed Pharmacother, 2018, 106: 1098-1107.
[14] LI G, WANG Q, LIU J, et al. Innovative strategies for enhanced tumor photodynamic therapy [J]. J Mater Chem B, 2021, 9(36): 7347-7370.
[15] DAI J, WU X, DING S, et al. Aggregation-induced emission photosensitizers: from molecular design to photodynamic therapy [J]. J Med Chem, 2020, 63(5): 1996-2012.
[16] LAN M, ZHAO S, LIU W, et al. Photosensitizers for photodynamic therapy [J]. Adv Healthc Mater, 2019, 8(13): e1900132. DOI: 10.1002/adhm.201900132.
[17] Kessel D, Oleinick N L. Cell death pathways associated with photodynamic therapy: an update [J]. Photochem Photobiol, 2018, 94(2): 213-218.
[18] ZHOU Z, SONG J, NIE L, et al. Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy [J]. Chem Soc Rev, 2016, 45(23): 6597-6626.
[19] LOVELL J F, LIU T W, CHEN J, et al. Activatable photosensitizers for imaging and therapy [J]. Chem Rev, 2010, 110(5): 2839-2857.
[20] LUCKY S S, SOO K C, ZHANG Y. Nanoparticles in photodynamic therapy [J]. Chem Rev, 2015, 115(4): 1990-2042.
[21] ATTIA M F, ANTON N, WALLYN J, et al. An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites [J]. J Pharm Pharmacol, 2019, 71(8): 1185-1198.
[22] TARIGHATNIA A, FOULADI M R, TOHIDKIA M R, et al. Engineering and quantification of bismuth nanoparticles as targeted contrast agent for computed tomography imaging in cellular and animal models [J]. J Drug Deliv Sci Technol, 2021, 66:124018. DOI: 10.1016/j.jddst.2021.102895.
[23] KOBAYASHI H, WATANABE R, CHOYKE P L. Improving conventional enhanced permeability and retention (EPR) effects: what is the appropriate target? [J]. Theranostics, 2013, 4(1): 81-89.
[24] CALIXTO G M, BERNEGOSSI J, DE FREITAS L M, et al. Nanotechnology-based drug delivery systems for photodynamic therapy of cancer: a review [J]. Molecules, 2016, 21(3): 342.
[25] LI Y, LI X, ZHOU F, et al. Nanotechnology-based photoimmunological therapies for cancer [J]. Cancer Lett, 2019, 442: 429-438.
[26] MESQUITA M Q, DIAS C J, GAMELAS S, et al. An insight on the role of photosensitizer nanocarriers for Photodynamic Therapy [J]. An Acad Bras Cienc, 2018, 90(1 Suppl 2): 1101-1130.
[27] LIU J, SHI J, NIE W, et al. Recent progress in the development of multifunctional nanoplatform for precise tumor phototherapy [J]. Adv Healthc Mater, 2021, 10(1): e2001207. DOI: 10.1002/adhm.202001207.
[28] KLEBOWSKI B, DEPCIUCH J, PARLINSKA-WOJTAN M, et al. Applications of noble metal-based nanoparticles in medicine [J]. Int J Mol Sci, 2018, 19(12):4031. DOI: 10.3390/ijms19124031.
[29] CAPEK I. Polymer decorated gold nanoparticles in nanomedicine conjugates [J]. Adv Colloid Interface Sci, 2017, 249: 386-399.
[30] LIU L, XIE H J, MU L M, et al. Functional chlorin gold nanorods enable to treat breast cancer by photothermal/photodynamic therapy [J]. Int J Nanomed, 2018, 13: 8119-8135.
[31] KALYANE D, RAVAL N, MAHESHWARI R, et al. Employment of enhanced permeability and retention effect (EPR): nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer [J]. Mater Sci Eng C Mater Biol Appl, 2019, 98: 1252-1276.
[32] MIOC A, MIOC M, GHIULAI R, et al. Gold nanoparticles as targeted delivery systems and theranostic agents in cancer therapy [J]. Curr Med Chem, 2019, 26(35): 6493-6513.
[33] KADKHODA J, TARIGHATNIA A, BARAR J, et al. Recent advances and trends in nanoparticles based photothermal and photodynamic therapy [J]. Photodiagnosis Photodyn Ther, 2022, 37: 102697. DOI: 10.1016/j.pdpdt.2021.102697.
[34] WU F, LIU Y, WU Y, et al. Chlorin e6 and polydopamine modified gold nanoflowers for combined photothermal and photodynamic therapy [J]. J Mater Chem B, 2020, 8(10): 2128-2138.
[35] CAROBELI L R, MEIRELLES L E F, DAMKE G, et al. Phthalocyanine and its formulations: a promising photosensitizer for cervical cancer phototherapy [J]. Pharmaceutics, 2021, 13(12):2057. DOI: 10.3390/pharmaceutics13122057.
[36] BŁASZKIEWICZ P, KOTKOWIAK M. Gold-based nanoparticles systems in phototherapy-current strategies [J]. Curr Med Chem, 2018, 25(42): 5914-5929.
[37] CAMERIN M, MORENO M, MARíN M J, et al. Delivery of a hydrophobic phthalocyanine photosensitizer using PEGylated gold nanoparticle conjugates for the in vivo photodynamic therapy of amelanotic melanoma [J]. Photochem Photobiol Sci, 2016, 15(5): 618-625.
[38] FREITAS L F, HAMBLIN M R, ANZENGRUBER F, et al. Zinc phthalocyanines attached to gold nanorods for simultaneous hyperthermic and photodynamic therapies against melanoma in vitro [J]. J Photochem Photobiol B, 2017, 173: 181-186.
[39] GARCÍA CALAVIA P, CHAMBRIER I, COOK M J, et al. Targeted photodynamic therapy of breast cancer cells using lactose-phthalocyanine functionalized gold nanoparticles [J]. J Colloid Interface Sci, 2018, 512: 249-259.
[40] PENON O, MARÍN M J, RUSSELL D A, et al. Water soluble, multifunctional antibody-porphyrin gold nanoparticles for targeted photodynamic therapy [J]. J Colloid Interface Sci, 2017, 496: 100-110.
[41] ALEA-REYES M E, SORIANO J, MORA-ESPÍ I, et al. Amphiphilic gemini pyridinium-mediated incorporation of Zn(II)meso-tetrakis(4-carboxyphenyl)porphyrin into water-soluble gold nanoparticles for photodynamic therapy [J]. Colloids Surf B Biointerfaces, 2017, 158: 602-609.
[42] LIU Z, XIE F, XIE J, et al. New-generation photosensitizer-anchored gold nanorods for a single near-infrared light-triggered targeted photodynamic-photothermal therapy [J]. Drug Deliv, 2021, 28(1): 1769-1784.
[43] ZHANG S, LV H, ZHAO J, et al. Synthesis of porphyrin-conjugated silica-coated Au nanorods for synergistic photothermal therapy and photodynamic therapy of tumor [J]. Nanotechnology, 2019, 30(26): 265102. DOI: 10.1088/1361-6528/ab0bd1.
[44] XU W, QIAN J, HOU G, et al. PEGylated hydrazided gold nanorods for pH-triggered chemo/photodynamic/photothermal triple therapy of breast cancer [J]. Acta Biomater, 2018, 82: 171-183.
[45] LIAW J W, KUO C Y, TSAI S W. The effect of quasi-spherical gold nanoparticles on two-photon induced reactive oxygen species for cell damage [J]. Nanomaterials (Basel), 2021, 11(5): 1180. DOI: 10.3390/nano11051180.
[46] KUROKAWA H, TANINAKA A, YOSHITOMI T, et al. Near-infrared light irradiation of porphyrin-modified gold nanoparticles promotes cancer-cell-specific Cytotoxicity [J]. Molecules, 2022, 27(4): 1238. DOI: 10.3390/molecules27041238.
[47] XU W, QIAN J, HOU G, et al. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer [J]. Acta Biomater, 2019, 83: 400-413.
[48] YANG Y, WANG S, WANG C, et al. Engineered targeted hyaluronic acid-glutathione-stabilized gold nanoclusters/graphene oxide-5-fluorouracil as a smart theranostic platform for stimulus-controlled fluorescence imaging-assisted synergetic chemo/phototherapy [J]. Chem Asian J, 2019, 14(9): 1418-1423.
[49] YOUSSEF Z, VANDERESSE R, COLOMBEAU L, et al. The application of titanium dioxide, zinc oxide, fullerene, and graphene nanoparticles in photodynamic therapy [J]. Cancer Nanotechnol, 2017, 8(1): 6. DOI: 10.1186/s12645-017-0032-2.
[50] WANG H, ZHOU J, FU Y, et al. Deeply infiltrating iRGD-graphene oxide for the intensive treatment of metastatic tumors through PTT-mediated chemosensitization and strengthened integrin targeting-based antimigration [J]. Adv Healthc Mater, 2021, 10(16): e2100536. DOI: 10.1002/adhm.202100536.
[51] HAN J, FENG Y, LIU Z, et al. Degradable GO-Nanocomposite hydrogels with synergistic photothermal and antibacterial response [J]. Polymer, 2021, 230:124018. DOI: 10.1016/j.polymer.2021.124018.
[52] SHARMA H, MONDAL S. Functionalized graphene oxide for chemotherapeutic drug delivery and cancer treatment: a promising material in nanomedicine [J]. Int J Mol Sci, 2020, 21(17):6280. DOI: 10.3390/ijms21176280.
[53] MA W, YANG H, HU Y, et al. Fabrication of PEGylated porphyrin/reduced graphene oxide/doxorubicin nanoplatform for tumour combination therapy [J]. Poly Int, 2021, 70(9): 1413-1420.
[54] LIANG J, CHEN B, HU J, et al. PH and thermal dual-responsive graphene oxide nanocomplexes for targeted drug delivery and photothermal-chemo/photodynamic synergetic therapy [J]. ACS Appl Bio Mater, 2019, 2(12): 5859-5871.
[55] DOS SANTOS M S C, GOUVêA A L, DE MOURA L D, et al. Nanographene oxide-methylene blue as phototherapies platform for breast tumor ablation and metastasis prevention in a syngeneic orthotopic murine model [J]. J Nanobiotechnol, 2018, 16(1): 9. DOI: 10.1186/s12951-018-0333-6.
[56] MA M, CHENG L, ZHAO A, et al. Pluronic-based graphene oxide-methylene blue nanocomposite for photodynamic/photothermal combined therapy of cancer cells [J]. Photodiagnosis Photodyn Ther, 2020, 29: 101640. DOI: 10.1016/j.pdpdt.2019.101640.
[57] CHOI H W, LIM J H, KIM C W, et al. Near-infrared light-triggered generation of reactive oxygen species and induction of local hyperthermia from indocyanine green encapsulated mesoporous silica-coated graphene oxide for colorectal cancer therapy [J]. Antioxidants (Basel), 2022, 11(1):174. DOI: 10.3390/antiox11010174.
[58] ZHANG J, GE J, SHULTZ M D, et al. In vitro and in vivo studies of single-walled carbon nanohorns with encapsulated metallofullerenes and exohedrally functionalized quantum dots [J]. Nano Lett, 2010, 10(8): 2843-2848.
[59] ZHANG M, MURAKAMI T, AJIMA K, et al. Fabrication of ZnPc/protein nanohorns for double photodynamic and hyperthermic cancer phototherapy [J]. Proc Natl Acad Sci USA, 2008, 105(39): 14773-14778.
[60] WANG T, WANG C. Functional metallofullerene materials and their applications in nanomedicine, magnetics, and electronics [J]. Small, 2019, 15(48): e1901522. DOI: 10.1002/smll.201901522.
[61] MORENO-LANCETA A, MEDRANO-BOSCH M, MELGAR-LESMES P. Single-walled carbon nanohorns as promising nanotube-derived delivery systems to treat cancer [J]. Pharmaceutics, 2020, 12(9):850. DOI: 10.3390/pharmaceutics12090850.
[62] GAO C, DONG P, LIN Z, et al. Near-infrared light responsive imaging-guided photothermal and photodynamic synergistic therapy nanoplatform based on carbon nanohorns for efficient cancer treatment [J]. Chemistry, 2018, 24(49): 12827-12837.
[63] GAO C, JIAN J, LIN Z, et al. Hypericin-loaded carbon nanohorn hybrid for combined photodynamic and photothermal therapy in vivo [J]. Langmuir, 2019, 35(25): 8228-8237.
[64] THOMAS S C, HARSHITA, MISHRA P K, et al. Ceramic nanoparticles: fabrication methods and applications in drug delivery [J]. Curr Pharm Des, 2015, 21(42): 6165-6188.
[65] KHAN I, SAEED K, KHAN I. Nanoparticles: Properties, applications and toxicities [J]. Arabian J Chem, 2019, 12(7): 908-931.
[66] KESSE S, BOAKYE-YIADOM K O, OCHETE B O, et al. Mesoporous silica nanomaterials: versatile nanocarriers for cancer theranostics and drug and gene delivery [J]. Pharmaceutics, 2019, 11(2):77. DOI: 10.3390/pharmaceutics11020077.
[67] ABU-DIEF A M, ALSEHLI M, AL-ENIZI A, et al. Recent advances in mesoporous silica nanoparticles for targeted drug delivery applications [J]. Curr Drug Deliv, 2022, 19(4): 436-450.
[68] BHARATHIRAJA S, MOORTHY M S, MANIVASAGAN P, et al. Chlorin e6 conjugated silica nanoparticles for targeted and effective photodynamic therapy [J]. Photodiagnosis Photodyn Ther, 2017, 19: 212-220.
[69] HUANG X, WU J, HE M, et al. Combined cancer chemo-photodynamic and photothermal therapy based on ICG/PDA/TPZ-loaded nanoparticles [J]. Mol Pharm, 2019, 16(5): 2172-2183.
[70] LIU Y, PAN Y, CAO W, et al. A tumor microenvironment responsive biodegradable CaCO₃/MnO₂-based nanoplatform for the enhanced photodynamic therapy and improved PD-L1 immunotherapy [J]. Theranostics, 2019, 9(23): 6867-6884.
[71] HOSSEINZADEH R, KHORSANDI K. Photodynamic effect of Zirconium phosphate biocompatible nano-bilayers containing methylene blue on cancer and normal cells [J]. Sci Rep, 2019, 9(1): 14899. DOI: 10.1038/s41598-019-51359-7.
[72] KAMILA S, MCEWAN C, COSTLEY D, et al. Diagnostic and therapeutic applications of quantum dots in nanomedicine [J]. Top Curr Chem, 2016, 370: 203-224.
[73] TRIPATHI S K, KAUR G, KHURANA R K, et al. Quantum dots and their potential role in cancer theranostics [J]. Crit Rev Ther Drug Carr Syst, 2015, 32(6): 461-502.
[74] MONROE J D, BELEKOV E, ER A O, et al. Anticancer photodynamic therapy properties of sulfur-doped graphene quantum dot and methylene blue preparations in mcf-7 breast cancer cell culture [J]. Photochem Photobiol, 2019, 95(6): 1473-1481.
[75] NENE L C, MANAGA M E, OLUWOLE D O, et al. The photo-physicochemical properties and in vitro photodynamic therapy activity of differently substituted-zinc (Ⅱ)-phthalocyanines and graphene quantum dots conjugates on MCF7 breast cancer cell line [J]. Inorg Chim Acta, 2019, 488: 304-311.
[76] ANAS A, AKITA H, HARASHIMA H, et al. Photosensitized breakage and damage of DNA by CdSe-ZnS quantum dots [J]. J Phys Chem B, 2008, 112(32): 10005-10011.
[77] YONG K T, DING H, ROY I, et al. Imaging pancreatic cancer using bioconjugated InP quantum dots [J]. ACS Nano, 2009, 3(3): 502-510.
[78] BILAN R, NABIEV I, SUKHANOVA A. Quantum dot-based nanotools for bioimaging, diagnostics, and drug delivery [J]. Chem Bio Chem, 2016, 17(22): 2103-2114.
[79] WENG K C, NOBLE C O, PAPAHADJOPOULOS-STERNBERG B, et al. Targeted tumor cell internalization and imaging of multifunctional quantum dot-conjugated immunoliposomes in vitro and in vivo [J]. Nano Lett, 2008, 8(9): 2851-2857.
[80] KADKHODA J, AKRAMI-HASAN-KOHAL M, TOHIDKIA M R, et al. Advances in antibody nanoconjugates for diagnosis and therapy: a review of recent studies and trends [J]. Int J Biol Macromol, 2021, 185: 664-678.
[81] WANG D, FEI B, HALIG L V, et al. Targeted iron-oxide nanoparticle for photodynamic therapy and imaging of head and neck cancer [J]. ACS Nano, 2014, 8(7): 6620-6632.
[82] NAM K C, HAN Y S, LEE J M, et al. Photo-functionalized magnetic nanoparticles as a nanocarrier of photodynamic anticancer agent for biomedical theragnostics [J]. Cancers (Basel), 2020, 12(3):571. DOI: 10.3390/cancers12030571.
[83] ZHANG P, WU G, ZHAO C, et al. Magnetic stomatocyte-like nanomotor as photosensitizer carrier for photodynamic therapy based cancer treatment [J]. Colloids Surf B Biointerfaces, 2020, 194: 111204. DOI: 10.1016/j.colsurfb.2020.111204.
[84] AMIRSHAGHAGHI A, YAN L, MILLER J, et al. Chlorin e6-coated superparamagnetic iron oxide nanoparticle (spion) nanoclusters as a theranostic agent for dual-mode imaging and photodynamic therapy [J]. Sci Rep, 2019, 9(1): 2613. DOI: 10.1038/s41598-019-39036-1.
[85] ZHU W, DONG Z, FU T, et al. Modulation of hypoxia in solid tumor microenvironment with MnO₂ nanoparticles to enhance photodynamic therapy [J]. Adv Funct Mater, 2016, 26(30): 5490-5498.
[86] YANG C, LIU Y, SU S, et al. A multifunctional oxygen-producing MnO₂-based nanoplatform for tumor microenvironment-activated imaging and combination therapy in vitro [J]. J Mater Chem B, 2020, 8(43): 9943-9950.
[87] LI B, WANG X, HONG S, et al. MnO₂ nanosheets anchored with polypyrrole nanoparticles as a multifunctional platform for combined photothermal/photodynamic therapy of tumors [J]. Food Funct, 2021, 12(14): 6334-6347.
[88] ZHANG Y, LV F, CHENG Y, et al. Pd@Au bimetallic nanoplates decorated mesoporous MnO₂ for synergistic nucleus-targeted nir-ii photothermal and hypoxia-relieved photodynamic therapy [J]. Adv Healthc Mater, 2020, 9(2): e1901528. DOI: 10.1002/adhm.201901528.
[89] LIU Y, JI M, WANG P. Recent advances in small copper sulfide nanoparticles for molecular imaging and tumor therapy [J]. Mol Pharm, 2019, 16(8): 3322-3332.
[90] WANG L, XU X, MU X, et al. Fe-doped copper sulfide nanoparticles for in vivo magnetic resonance imaging and simultaneous photothermal therapy [J]. Nanotechnology, 2019, 30(41): 415101. DOI: 10.1088/1361-6528/ab2c13.
[91] SHI H, SUN Y, YAN R, et al. Magnetic semiconductor Gd-Doping CuS nanoparticles as activatable nanoprobes for bimodal imaging and targeted photothermal therapy of gastric tumors [J]. Nano Lett, 2019, 19(2): 937-947.
[92] LI Q, REN J, CHEN Q, et al. A HMCuS@MnO₂ nanocomplex responsive to multiple tumor environmental clues for photoacoustic/fluorescence/magnetic resonance trimodal imaging-guided and enhanced photothermal/photodynamic therapy [J]. Nanoscale, 2020, 12(23): 12508-12521.
[93] HUANG J, HUANG Y, XUE Z, et al. Tumor microenvironment responsive hollow mesoporous Co₉S₈@MnO₂-ICG/DOX intelligent nanoplatform for synergistically enhanced tumor multimodal therapy [J]. Biomaterials, 2020, 262: 120346. DOI: 10.1016/j.biomaterials.2020.120346.